Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132585) titled 'Tracking Treatments and Outcomes in Neuroimmune Diseases' on Sept. 16.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: NanJing First Hospital
Condition:
myasthenia gravis (MG)
chronic inflammatory demyelinating polyneuropathy (CIDP)
neuromyelitis optica spectrum disorder (NMOSD)
multiple sclerosis (MS)
and other neuroimmune disorders.
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-11-06
Target Sample Size: Neuroimmune disease patients:300;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=293788
P...